Endocrinology
News
FDA issues warning on insulin pump cybersecurity weakness
The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the...
Video
Bisphosphonates before denosumab may prevent postdenosumab BMD rebound effect
MADRID – Preliminary results suggest that using denosumab after bisphosphonates for rebound is effective and monitoring bone turnover markers at...
Conference Coverage
Levothyroxine did not reduce fatigue in older patients with hypothyroidism
WASHINGTON – No significant differences between the effects of levothyroxine and placebo on fatigability were observed.
Conference Coverage
CGMs on the rise: New goals set time in range
The targets “should be considered an integral component of CGM data analysis and day-to-day treatment decision making.”
Conference Coverage
How to reverse type 2 diabetes with a crash diet: the DiRECT approach
SAN FRANCISCO – A few months of a medically supervised liquid diet; durable remission at 2 years.
From the Journals
Younger men and women show similar rates of osteopenia
A new study finds that about a quarter of both men and women in early middle age have osteopenia in at least one site.
Conference Coverage
Emerging data support anabolic-first regimens for severe osteoporosis
LOS ANGELES –
Conference Coverage
New insights, advances offer better perspective on AGHD
LOS ANGELES – There’s more clarity about benefits of treatment for adult growth hormone deficiency.
Conference Coverage
Subclinical hypothyroidism may be associated with increased cancer risks
LOS ANGELES – One of the findings includes a possible protective effect from untreated hypothyroidism against...
Conference Coverage
Mystery hypoglycemia case highlights troublesome diagnosis
LOS ANGELES – Nothing seemed to help a 69-year-old female patient, until an alert nurse noticed something important...
Conference Coverage
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart...